Shionogi Company Limited

Purdue Pharma L.p.

Jeffrey Michael Marra

Xiaoming Zhou

Naoki Tsuno

Tatsuhiko Ueno

The present disclosure relates to Oxime-Substituted Quinoxaline-Type Piperidine Compounds, such as those of Formula (I): and the pharmaceutically acceptable salts and solvates thereof, wherein R, R, R, R, R, R, Q, Y, Z, A, B, and a are as defined herein; compositions comprising an effective amount of an Oxime-Substituted Quinoxaline-Type Piperidine Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of an Oxime-Substituted Quinoxaline-Type Piperidine Compound.

Growing community of inventors

Old Bridge, NJ, United States of America

Jeffrey Michael Marra